Oxford Biomedica (LON:OXB) Share Price Crosses Above 200-Day Moving Average – Here’s Why

Oxford Biomedica plc (LON:OXB)’s stock price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 389.64 ($4.86) and traded as high as GBX 413.50 ($5.16). Oxford Biomedica shares last traded at GBX 410 ($5.12), with a volume of 155,898 shares.

Oxford Biomedica Price Performance

The stock has a market capitalization of £431.98 million, a PE ratio of -284.72 and a beta of 1.09. The company has a current ratio of 2.35, a quick ratio of 1.67 and a debt-to-equity ratio of 154.88. The firm has a 50 day moving average price of GBX 419.85 and a 200 day moving average price of GBX 389.64.

Oxford Biomedica Company Profile

Oxford Biomedica (LSE: OXB) is a quality and innovation-led cell and gene therapy CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world.

One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.